These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. [Tissue selectivity of calcium channel blockers]. Godfraind T C R Seances Soc Biol Fil; 1998; 192(1):121-35. PubMed ID: 9759358 [TBL] [Abstract][Full Text] [Related]
26. [The advantages of treatment with calcium blockers in arterial hypertension: a hope or a reality?]. Dorobanţu M; Gherasim L Med Interna; 1993; 45(1-2):24-34. PubMed ID: 8081688 [No Abstract] [Full Text] [Related]
27. Calcium, vascular smooth muscle, and calcium entry blockers in hypertension. Cohn JN Ann Intern Med; 1983 May; 98(5 Pt 2):806-9. PubMed ID: 6847019 [TBL] [Abstract][Full Text] [Related]
28. Calcium channel function in hypertension. Hermsmeyer K J Hum Hypertens; 1993 Apr; 7(2):173-6. PubMed ID: 8389872 [TBL] [Abstract][Full Text] [Related]
29. [Use of calcium channel blockers in neurology]. Ryglewicz D; Członkowska A Neurol Neurochir Pol; 1988; 22(3):240-5. PubMed ID: 2851746 [No Abstract] [Full Text] [Related]
30. [Hypertension, coronary disease and calcium antagonists]. Dal Palù C Cardiologia; 1984; 29(9-10):433-4. PubMed ID: 6543506 [No Abstract] [Full Text] [Related]
31. [The role of calcium in the regulation of normal vascular tone and in arterial hypertension]. Ramón de Berrazueta J Rev Esp Cardiol; 1999; 52 Suppl 3():25-33. PubMed ID: 10614146 [TBL] [Abstract][Full Text] [Related]
33. Ca2+ channel subtypes and pharmacology in the kidney. Hayashi K; Wakino S; Sugano N; Ozawa Y; Homma K; Saruta T Circ Res; 2007 Feb; 100(3):342-53. PubMed ID: 17307972 [TBL] [Abstract][Full Text] [Related]
34. [Also for problem cases; successful first line therapy]. MMW Fortschr Med; 2005 Feb; 147(5):47. PubMed ID: 15766030 [No Abstract] [Full Text] [Related]
35. Calcium channel blockers in the treatment of hypertension. Raspa RF; Wilson CC Am Fam Physician; 1993 Sep; 48(3):461-70. PubMed ID: 8362695 [TBL] [Abstract][Full Text] [Related]
36. [Calcium antagonists in the treatment of patients with diseases of the cardiovascular system (review of foreign literature)]. Smolenskii VS; Abinder AA; Kamenker SM Klin Med (Mosk); 1985 Feb; 63(2):17-27. PubMed ID: 3887022 [No Abstract] [Full Text] [Related]
39. [A free radical mechanism for inhibition of arteriosclerosis development with calcium antagonists]. Andrzejak R; Goch JH; Jurga M Postepy Hig Med Dosw; 1995; 49(5):645-59. PubMed ID: 8677227 [TBL] [Abstract][Full Text] [Related]
40. A theoretic consideration on the use of calcium antagonists in the treatment of hypertension. Van Breemen C; Lukeman S; Cauvin C Am J Med; 1984 Oct; 77(4A):26-30. PubMed ID: 6091448 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]